Maxigen Biotech (Taiwan) Alpha and Beta Analysis

1783 Stock  TWD 52.70  1.90  3.74%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Maxigen Biotech. It also helps investors analyze the systematic and unsystematic risks associated with investing in Maxigen Biotech over a specified time horizon. Remember, high Maxigen Biotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Maxigen Biotech's market risk premium analysis include:
Beta
(0.29)
Alpha
0.29
Risk
2
Sharpe Ratio
0.15
Expected Return
0.3
Please note that although Maxigen Biotech alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Maxigen Biotech did 0.29  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Maxigen Biotech stock's relative risk over its benchmark. Maxigen Biotech has a beta of 0.29  . As returns on the market increase, returns on owning Maxigen Biotech are expected to decrease at a much lower rate. During the bear market, Maxigen Biotech is likely to outperform the market. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Maxigen Biotech Backtesting, Maxigen Biotech Valuation, Maxigen Biotech Correlation, Maxigen Biotech Hype Analysis, Maxigen Biotech Volatility, Maxigen Biotech History and analyze Maxigen Biotech Performance.

Maxigen Biotech Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Maxigen Biotech market risk premium is the additional return an investor will receive from holding Maxigen Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Maxigen Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Maxigen Biotech's performance over market.
α0.29   β-0.29

Maxigen Biotech expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Maxigen Biotech's Buy-and-hold return. Our buy-and-hold chart shows how Maxigen Biotech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Maxigen Biotech Market Price Analysis

Market price analysis indicators help investors to evaluate how Maxigen Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Maxigen Biotech shares will generate the highest return on investment. By understating and applying Maxigen Biotech stock market price indicators, traders can identify Maxigen Biotech position entry and exit signals to maximize returns.

Maxigen Biotech Return and Market Media

The median price of Maxigen Biotech for the period between Sun, Dec 1, 2024 and Sat, Mar 1, 2025 is 49.45 with a coefficient of variation of 4.28. The daily time series for the period is distributed with a sample standard deviation of 2.11, arithmetic mean of 49.19, and mean deviation of 1.76. The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About Maxigen Biotech Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Maxigen or other stocks. Alpha measures the amount that position in Maxigen Biotech has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Maxigen Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Maxigen Biotech's short interest history, or implied volatility extrapolated from Maxigen Biotech options trading.

Build Portfolio with Maxigen Biotech

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Maxigen Stock Analysis

When running Maxigen Biotech's price analysis, check to measure Maxigen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maxigen Biotech is operating at the current time. Most of Maxigen Biotech's value examination focuses on studying past and present price action to predict the probability of Maxigen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maxigen Biotech's price. Additionally, you may evaluate how the addition of Maxigen Biotech to your portfolios can decrease your overall portfolio volatility.